Why does electroCore exist?

Watch our video featuring Dan Goldberger, CEO at electroCore. Learn how electroCore’s patented vagus nerve stimulation technology, including gammaCore non-invasive vagus nerve stimulator (nVNS), is providing a new approach to the treatment of primary headache conditions and enhancing overall well-being.


Indications and Important Safety Information
gammaCore™ is intended to provide non-invasive vagus nerve stimulation (nVNS) on the side of the neck for preventive treatment of migraine and the acute treatment of pain associated with migraine in patients 12 and older. gammaCore is also indicated for adjunctive use for preventive treatment of cluster headache, acute treatment of episodic cluster headache, and treatment of hemicrania continua and paroxysmal hemicrania in
adult patients.

gammaCore is available by prescription only. US Federal Law restricts this device to sale by or on the order of a licensed health care provider.

Truvaga™ products are general wellness products and as such have not been evaluated by the US Food and Drug Administration. They are not intended to diagnose, treat, cure, or prevent any disease or condition.